Skip to main content

ANZ Bone & Mineral Society

ANZ Bone & Mineral Society

If you don't have time to watch these lectures now, save the lectures to your phone using the armchair medical app and listen to them while exercising or commuting
Get the App: It's free to download and free to trial for a month - it also contains over 1,500 Australian GP Lectures (Click on the "Browse" button above to see all the lectures available)

Download the app: https://itunes.apple.com/au/app/armchair-medical/id1087154093?mt=8
or https://play.google.com/store/apps/details?id=tv.vhx.armchairmedical&hl=en

Subscribe

ANZ Bone & Mineral Society

29:32

Novel targets of treatment for myeloma-bone interaction Prof Masahiro Abe

Novel targets of treatment for myeloma-bone interaction Prof Masahiro Abe
30:35

Glucocorticoids, bone and systemic metabolism Hong Zhou presented by Markus Seibel

Glucocorticoids, bone and systemic metabolism Hong Zhou presented by Markus Seibel
36:10

Tumour cell dormancy in the skeleton Prof Peter Croucher

Tumour cell dormancy in the skeleton Prof Peter Croucher
31:53

Cancer-associated muscle weakness What's bone got to do with it Prof Theresa Guise

Cancer-associated muscle weakness What's bone got to do with it Prof Theresa Guise
31:14

GWAS Changing our understanding of osteoporosis and other bone disorders Prof Emma Duncan

GWAS Changing our understanding of osteoporosis and other bone disorders Prof Emma Duncan
31:44

Using ultra high-throughput single cell sequencing to understanding cellular heterogeneity Joseph Powell

Using ultra high-throughput single cell sequencing to understanding cellular heterogeneity Joseph Powell
30:28

Informing GWAS using systems genetics Assoc Prof Charles Farber

Informing GWAS using systems genetics Assoc Prof Charles Farber
$The genetic architecture of osteoporosis and implications for fracture prediction Prof Emma Duncan$

13:41

The genetic architecture of osteoporosis and implications for fracture prediction Prof Emma Duncan

The genetic architecture of osteoporosis and implications for fracture prediction Prof Emma Duncan
16:33

Genetic investigation of monogenic bone disease using whole exome sequencing Dr Aideen McInerney-Leo

Genetic investigation of monogenic bone disease using whole exome sequencing Dr Aideen McInerney-Leo
14:29

Genetic investigations of osteoporosis using genome wide association studies Assoc Prof Paul Leo

Genetic investigations of osteoporosis using genome wide association studies Assoc Prof Paul Leo
18:00

Using mouse genetics to inform human skeletal disorders Scott Youlten

Using mouse genetics to inform human skeletal disorders Scott Youlten
16:50

Using genetics to guide drug selection Matt Brown

Using genetics to guide drug selection Matt Brown
13:38

Leveraging Mendelian randomization strategies to identify modifiable lifestyle factors causally related to osteoporosis pathogenesis David Evans

Leveraging Mendelian randomization strategies to identify modifiable lifestyle factors causally related to osteoporosis pathogenesis David Evans
21:39

What is bone quality Prof Ego Seeman

What is bone quality Prof Ego Seeman
17:57

Bone histology Benefits, limitations and pitfalls Assoc Prof Natalie Sims

Bone histology Benefits, limitations and pitfalls Assoc Prof Natalie Sims
11:57

Fourier Transform InfraRed Spectroscopy imaging in bone What does it tell us Christina Vrahnas

Fourier Transform InfraRed Spectroscopy imaging in bone What does it tell us Christina Vrahnas
12:44

Quantitative ultrasound assessment of bone quality - Time for a new paradigm Prof Christian Langton

Quantitative ultrasound assessment of bone quality - Time for a new paradigm Prof Christian Langton
20:00

Mechanical testing combined with imaging Egon Perilli

Mechanical testing combined with imaging Egon Perilli
1:39:59

New Investigator Session

New Investigator Session
21:37

Anti-sclerostin antibody treatment prevents myeloma induced bone disease and increases bone strength Michelle Mc Donald

Anti-sclerostin antibody treatment prevents myeloma induced bone disease and increases bone strength Michelle Mc Donald
18:01

OA Mutations in MAP3K7 and TAB2 cause autosomal dominant frontometaphyseal dysplasia Emma Wade

OA Mutations in MAP3K7 and TAB2 cause autosomal dominant frontometaphyseal dysplasia Emma Wade
$Fracture associated mortality fracture vs co-morbidity the 45 and up study Weiwen Chen$

17:44

Fracture associated mortality fracture vs co-morbidity the 45 and up study Weiwen Chen

Fracture associated mortality fracture vs co-morbidity the 45 and up study Weiwen Chen
$Deterioration in bone microstructure identifies women at risk for fractures Prof Ego Seemen$

21:23

Deterioration in bone microstructure identifies women at risk for fractures Prof Ego Seemen

Deterioration in bone microstructure identifies women at risk for fractures Prof Ego Seemen
19:07

OA Tram2 is a novel genetic determinant of bone mass and strength Victoria Leitch

OA Tram2 is a novel genetic determinant of bone mass and strength Victoria Leitch